Durect Corporation
Drug Manufacturers - Specialty & Generic
Healthcare
DRRX
31.16 M shares
NASDAQ US
traded
10 Sep 2025
listed
no
open
1.93
52 week high
1.96
high
1.95
52 week low
0.00
low
1.91
growth
3.80 %
previous Close
1.93
P/E ratio
market cap
59.29 M
div yield
0
usd
Jun 2025
qoq
revenue
447 K
39.25 %
net incoming
-2.27 M
46.48 %
eps
0.00 %
46.15 %
eps surprise
46.15 %
net profit margin
-506.71 %
811.00 %
operating incoming
-2.80 M
32.28 %
net change in cash
0.00 %
cash on hand
6.50 M
-18.35 %
cost of revenue
7.00 K
0.00 %
top top